CareTria, formerly Knipper Health, rebranded to enhance its comprehensive therapy initiation platform, integrating digital onboarding and multi-modal fulfillment. The acquisition of eBlu Solutions ...
It’s been more than ten years since the FDA signed off on the United States’ first biosimilar product, opening up what was ...
Sip or Die takes the phrase “pick your poison” literally by asking you to drink from a selection of vials that are either safe or have detrimental effects. The problem is, you don’t know which is ...
The Council and the European Parliament have reached an agreement on the ‘pharma package’, a new set of rules that will increase patients' access to medicine and make the EU’s pharmaceutical sector ...
AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...
A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the harms of opioids. U.S. Bankruptcy Judge Sean Lane gave ...
A federal judge officially approved drugmaker Purdue Pharma's $7.4 billion deal to settle thousands of lawsuits over the toll of the opioid epidemic and pay victims, prosecutors in the case told USA ...
Members of the Sackler family who own OxyContin maker Purdue Pharma must pay billions of dollars to settle a flood of lawsuits over the harms of opioids, under a new deal that was formally approved by ...
Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of their personal fortune to states, localities, tribes and others harmed in the ...
NEW YORK, NY / ACCESS Newswire / November 12, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding aTyr Pharma, Inc. (ATYR) class action securities lawsuit A Class Action lawsuit was filed on ...
Health Affairs' Jeff Byers welcomes Stacie Dusetzina of Vanderbilt University Medical Center and David Simon of the University of Connecticut back to the pod to the current state of drug prices, how ...
President Donald Trump celebrated a long-promised victory Tuesday, announcing that he had used the threat of tariffs to prod pharmaceutical giant Pfizer into cutting U.S. drug prices. But the deal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback